BOSTON, April 10,
2024 /PRNewswire/ -- Haemonetics Corporation (NYSE:
HAE) announced that the Company intends to publish fourth quarter
and fiscal year 2024 financial results at 6:00 am ET on Thursday, May 9, 2024. The Company
will hold a conference call with investors and analysts to discuss
results and answer questions at 8:00 am
ET on May 9, 2024.
The call can be accessed via teleconference at: Q4 2024
Haemonetics Corporation Earnings Conference Call. Once
registration is completed, participants will receive a dial-in
number along with a personalized PIN to access the call. While not
required, it is recommended that participants join 10 minutes prior
to the event start.
A live webcast of the call can be accessed on Haemonetics'
investor relations website. Webcast Link:
https://edge.media-server.com/mmc/p/5cppxurr
A replay of the conference call and webcast will be available
for one year beginning on May 9, 2024
at 11:00 am ET using the conference
call webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company
dedicated to providing a suite of innovative medical products and
solutions for customers, to help them improve patient care and
reduce the cost of healthcare. Our technology addresses important
medical markets: blood and plasma component collection, the
surgical suite and hospital transfusion services. To learn more
about Haemonetics, visit www.haemonetics.com.
Investor
Contacts:
|
|
Olga Guyette, Sr.
Director-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
(781)
356-9763
|
(203)
733-4987
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
Media
Contact:
|
|
Josh Gitelson,
Director-Global Communications
|
|
(781)
356-9776
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-fourth-quarter-and-fiscal-year-2024-results-may-9-2024-302113652.html
SOURCE Haemonetics Corporation